| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |